cidofovir anhydrous has been researched along with cmx 001 in 28 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (17.86) | 29.6817 |
2010's | 16 (57.14) | 24.3611 |
2020's | 7 (25.00) | 2.80 |
Authors | Studies |
---|---|
Beadle, JR; Ciesla, SL; Hartline, C; Hostetler, KY; Keith, KA; Kern, ER; Wan, WB | 1 |
Hruby, DE; Jordan, R; Keith, KA; Kern, ER; Painter, GR; Prichard, MN; Quenelle, DC; Robertson, A | 1 |
Beadle, JR; Collins, DJ; Herrod, BP; Hostetler, KY; Keith, KA; Kern, ER; Quenelle, DC; Trahan, J | 1 |
Chou, KC; González-Díaz, H; Martinez de la Vega, O; Prado-Prado, FJ; Ubeira, FM; Uriarte, E | 1 |
Andrei, G; Balzarini, J; Dračínský, M; Holý, A; Krečmerová, M; Snoeck, R; Tichý, T | 1 |
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Almond, M; Buller, RM; Lampert, B; Oberle, C; Painter, G; Parker, S; Robertson, A; Touchette, E; Trost, LC | 1 |
Godkin, S; Lampert, B; Painter, G; Painter, W; Robertson, A; Trost, LC | 1 |
Alfson, ED; Awosika, OO; Ciarlini, P; Drew, C; Folkerth, RD; Johnson, EL; Klein, JP; Koo, S; Lyons, JL; Marty, F; Phillips, RE; Zaki, S | 1 |
Hartline, CB; James, SH; Lanier, ER; Price, NB; Prichard, MN | 1 |
Damon, IK; Foster, S; Gates, I; Lanier, ER; Li, Y; Olson, VA; Smith, SK; Trost, LC | 1 |
Buller, RM; Spencer, JF; Tollefson, AE; Toth, K; Wold, WS; Ying, B | 1 |
Foster, SA; Godin, SJ; Keilholz, L; Khouri, J; Long, J; Rose, ML; Trost, LC | 1 |
Toth, K; Wold, WS | 1 |
Albariño, C; Dyall, J; Flint, M; Foster, S; Hensley, LE; Lanier, ER; McMullan, LK; Nichol, ST; Olinger, GG; Sethna, P; Spiropoulou, CF | 1 |
Chou, S; Ercolani, RJ; Lanier, ER | 1 |
Edelmann, A; Hofmann, J; Kühl, JS; Sauerbrei, A; Voigt, S | 1 |
Hayden, RT; Ison, MG | 1 |
Green, M; Lopez, SMC; Michaels, MG | 1 |
DeVita, AV; Gentry, BG; Markovich, KC; O'Brien, MS; Selleseth, D; Sethna, P | 1 |
Bae, A; Bambara, RA; Chamberlain, JM; Dewhurst, S; Lanier, R; Sethna, P; Sortino, K | 1 |
Bar-On, S; Haynes, RK; Lantsberg, D; Laskov, I; Oiknine-Djian, E; Panet, A; Wolf, DG | 1 |
Cottrell, ML; Dunn, JA; Guzman, BB; Schauer, AP; Sykes, C | 1 |
Sassine, J; Siegrist, EA | 1 |
Hirano, D; Ishikane, M; Kataoka, Y; Kuroda, N; Shimizu, T | 1 |
Akhtar, N; Al-Tammemi, AB; Al-Tawfiq, JA; Chatterjee, C; Chattu, VK; Dwivedi, P; Mohanty, A; Nowrouzi-Kia, B; Padhi, BK; Pradhan, A; Rodriguez-Morales, AJ; Sah, R; Satapathy, P; Shamim, MA; Tripathy, S; Veeramachaneni, SD | 1 |
Bechtel, M; Bojkova, D; Ciesek, S; Cinatl, J; Corman, VM; Göttig, S; Kandler, JD; Kippenberger, S; Michaelis, M; Rabenau, HF; Rothenburger, T; Schneider, J; Steinhorst, K; Tietgen, M; Wass, MN; Zöller, N | 1 |
Bansal, N; Bansal, S; Chaudhay, R; Gujjar, P; Gupta, S; Verma, I | 1 |
5 review(s) available for cidofovir anhydrous and cmx 001
Article | Year |
---|---|
Adenovirus.
Topics: Adenoviridae Infections; Antiviral Agents; Cidofovir; Cytosine; Diagnostic Tests, Routine; Disease Susceptibility; Drug Monitoring; Humans; Immunocompromised Host; Organophosphonates | 2016 |
Adenovirus infection in pediatric transplant recipients: are effective antiviral agents coming our way?
Topics: Adenoviridae Infections; Antiviral Agents; Child; Cidofovir; Cytosine; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Organ Transplantation; Organophosphonates; Pediatrics; Transplant Recipients | 2018 |
Antivirals With Activity Against Mpox: A Clinically Oriented Review.
Topics: Animals; Antiviral Agents; Cidofovir; Cytosine; Humans; Monkeypox virus; Mpox (monkeypox); Organophosphonates | 2023 |
Lack of clinical evidence of antiviral therapy for human monkeypox: A scoping review.
Topics: Antiviral Agents; Benzamides; Cidofovir; Humans; Mpox (monkeypox) | 2023 |
The use of antivirals in the treatment of human monkeypox outbreaks: a systematic review.
Topics: Antiviral Agents; Benzamides; Cidofovir; Disease Outbreaks; Humans; Isoindoles; Monkeypox virus; Mpox (monkeypox); Trifluridine | 2023 |
1 trial(s) available for cidofovir anhydrous and cmx 001
Article | Year |
---|---|
First pharmacokinetic and safety study in humans of the novel lipid antiviral conjugate CMX001, a broad-spectrum oral drug active against double-stranded DNA viruses.
Topics: Administration, Oral; Adolescent; Adult; Antiviral Agents; Area Under Curve; Biological Availability; Capsule Endoscopy; Cidofovir; Cytosine; DNA Viruses; Double-Blind Method; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Intraocular Pressure; Kidney Function Tests; Male; Middle Aged; Organophosphonates; Placebos; United States | 2012 |
22 other study(ies) available for cidofovir anhydrous and cmx 001
Article | Year |
---|---|
Synthesis and antiviral evaluation of alkoxyalkyl derivatives of 9-(S)-(3-hydroxy-2-phosphonomethoxypropyl)adenine against cytomegalovirus and orthopoxviruses.
Topics: Adenine; Antiviral Agents; Cell Line; Cytomegalovirus; Esters; Humans; Organophosphonates; Orthopoxvirus; Stereoisomerism; Structure-Activity Relationship | 2006 |
Synergistic efficacy of the combination of ST-246 with CMX001 against orthopoxviruses.
Topics: Administration, Oral; Animals; Antiviral Agents; Benzamides; Cells, Cultured; Chlorocebus aethiops; Cowpox virus; Cytosine; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Humans; Isoindoles; Male; Mice; Mice, Inbred BALB C; Organophosphonates; Orthopoxvirus; Poxviridae Infections; Treatment Outcome; Vaccinia virus; Vero Cells; Virus Replication | 2007 |
Effect of oral treatment with hexadecyloxypropyl-[(S)-9-(3-hydroxy-2- phosphonylmethoxypropyl)adenine] [(S)-HPMPA] or octadecyloxyethyl-(S)-HPMPA on cowpox or vaccinia virus infections in mice.
Topics: Adenine; Administration, Oral; Animals; Antiviral Agents; Cowpox; Kidney; Liver; Lung; Mice; Molecular Structure; Organophosphonates; Spleen; Vaccinia virus | 2007 |
Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
Topics: Anti-Infective Agents; Antiviral Agents; Artificial Intelligence; Computer Simulation; Drug Evaluation, Preclinical; Molecular Structure; Quantitative Structure-Activity Relationship | 2009 |
New prodrugs of Adefovir and Cidofovir.
Topics: Adenine; Animals; Antiviral Agents; Cell Line, Tumor; Cidofovir; Cytomegalovirus; Cytosine; Herpesvirus 3, Human; HIV; Humans; Organophosphonates; Prodrugs; Simplexvirus | 2011 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Efficacy of therapeutic intervention with an oral ether-lipid analogue of cidofovir (CMX001) in a lethal mousepox model.
Topics: Administration, Oral; Animals; Antiviral Agents; Cidofovir; Cytosine; Ectromelia virus; Ectromelia, Infectious; Ether; Female; Hepatocytes; Humans; Mice; Mice, Inbred A; Organophosphonates | 2008 |
Fatal adenovirus encephalomyeloradiculitis in an umbilical cord stem cell transplant recipient.
Topics: Adenoviridae Infections; Antiviral Agents; Cidofovir; Cord Blood Stem Cell Transplantation; Cytosine; Encephalomyelitis; Fatal Outcome; Female; Humans; Leukemia, Prolymphocytic, T-Cell; Middle Aged; Organophosphonates | 2013 |
Selection and recombinant phenotyping of a novel CMX001 and cidofovir resistance mutation in human cytomegalovirus.
Topics: Amino Acid Sequence; Antiviral Agents; Base Sequence; Cells, Cultured; Chromosomes, Artificial, Bacterial; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Mutation; Organophosphonates; Phenotype; Sequence Analysis, DNA | 2013 |
In vitro efficacy of brincidofovir against variola virus.
Topics: Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; Cidofovir; Cytosine; Disease Models, Animal; DNA, Viral; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Organophosphonates; Smallpox; Variola virus | 2014 |
Cidofovir and brincidofovir reduce the pathology caused by systemic infection with human type 5 adenovirus in immunosuppressed Syrian hamsters, while ribavirin is largely ineffective in this model.
Topics: Adenoviridae Infections; Adenoviruses, Human; Alanine Transaminase; Animals; Body Weight; Cell Line; Cidofovir; Cytosine; Disease Models, Animal; Female; Humans; Immunocompromised Host; Liver; Mesocricetus; Organophosphonates; Ribavirin; Survival Analysis; Treatment Outcome; Viral Load | 2014 |
The efficacy and pharmacokinetics of brincidofovir for the treatment of lethal rabbitpox virus infection: a model of smallpox disease.
Topics: Animals; Antibodies, Neutralizing; Antibodies, Viral; Antiviral Agents; Cidofovir; Cytosine; Disease Models, Animal; Humans; Injections, Intradermal; Organophosphonates; Rabbits; Random Allocation; Smallpox; Vaccinia; Vaccinia virus; Variola virus | 2015 |
New drug on the horizon for treating adenovirus.
Topics: Adenoviridae Infections; Adenoviruses, Human; Adoptive Transfer; Animals; Antiviral Agents; Cidofovir; Cytosine; DNA, Viral; Humans; Immunocompromised Host; Organophosphonates; T-Lymphocytes | 2015 |
The lipid moiety of brincidofovir is required for in vitro antiviral activity against Ebola virus.
Topics: Animals; Antiviral Agents; Cell Line, Tumor; Chlorocebus aethiops; Cidofovir; Cytosine; Drug Evaluation, Preclinical; Ebolavirus; HeLa Cells; Hemorrhagic Fever, Ebola; Human Umbilical Vein Endothelial Cells; Humans; Lipids; Male; Organophosphonates; Structure-Activity Relationship; Vero Cells; Virus Replication | 2016 |
Novel Cytomegalovirus UL54 DNA Polymerase Gene Mutations Selected In Vitro That Confer Brincidofovir Resistance.
Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Gene Expression; Humans; Microbial Sensitivity Tests; Mutation; Organophosphonates; Protein Domains; Viral Proteins | 2016 |
Brincidofovir clearance of acyclovir-resistant herpes simplex virus-1 and adenovirus infection after stem cell transplantation.
Topics: Acyclovir; Adenoviridae; Adenovirus Infections, Human; Antibiotic Prophylaxis; Antiviral Agents; Child, Preschool; Cidofovir; Cytosine; DNA, Viral; Drug Resistance, Viral; Epstein-Barr Virus Infections; Female; Foscarnet; Hematopoietic Stem Cell Transplantation; Herpes Simplex; Herpes Zoster; Herpesvirus 1, Human; Herpesvirus 3, Human; Herpesvirus 4, Human; Humans; Immunocompromised Host; Meningoencephalitis; Mucositis; Myelodysplastic Syndromes; Organophosphonates; Rituximab; Viral Load | 2016 |
In vitro evaluation of current and novel antivirals in combination against human cytomegalovirus.
Topics: Antiviral Agents; Benzimidazoles; Cell Line; Cidofovir; Cyclopropanes; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Antagonism; Drug Combinations; Drug Resistance, Viral; Drug Synergism; Drug Therapy, Combination; Endodeoxyribonucleases; Fibroblasts; Foscarnet; Ganciclovir; Guanine; Humans; Nucleic Acid Synthesis Inhibitors; Organophosphonates; Ribonucleosides; Viral Proteins; Virus Replication | 2018 |
Cidofovir Diphosphate Inhibits Adenovirus 5 DNA Polymerase via both Nonobligate Chain Termination and Direct Inhibition, and Polymerase Mutations Confer Cidofovir Resistance on Intact Virus.
Topics: Adenovirus Infections, Human; Adenoviruses, Human; Antiviral Agents; Cidofovir; Cytosine; DNA Primers; DNA-Directed DNA Polymerase; DNA, Viral; Dose-Response Relationship, Drug; Humans; Kinetics; Mutation; Organophosphonates; Real-Time Polymerase Chain Reaction; Recombinant Proteins; Viral Proteins; Virus Replication | 2019 |
Artemisone demonstrates synergistic antiviral activity in combination with approved and experimental drugs active against human cytomegalovirus.
Topics: Acetates; Antiviral Agents; Artemisinins; Benzimidazoles; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Interactions; Drug Synergism; Drugs, Investigational; Female; Ganciclovir; Humans; Organ Culture Techniques; Organophosphonates; Placenta; Pregnancy; Quinazolines; Ribonucleosides | 2019 |
A quantitative LC-MS/MS method for the determination of tissue brincidofovir and cidofovir diphosphate in a MuPyV-infected mouse model.
Topics: Animals; Antiviral Agents; Brain Chemistry; Chromatography, High Pressure Liquid; Cidofovir; Cytosine; Kidney; Mice; Mice, Inbred C57BL; Organophosphonates; Polyomavirus Infections; Spleen; Tandem Mass Spectrometry | 2021 |
Repurposing of the antibiotic nitroxoline for the treatment of mpox.
Topics: Anti-Bacterial Agents; Antiviral Agents; Cidofovir; Drug Repositioning; Humans; Mpox (monkeypox); Nitroquinolines | 2023 |
Recent Advances in the Prevention and Management of Monkeypox Viral Infection in Humans.
Topics: Animals; Antiviral Agents; Benzamides; Cidofovir; Humans; Monkeypox virus; Mpox (monkeypox); Vaccines | 2023 |